van Leeuwen Hans, Okuwaki Mitsuru, Hong Rui, Chakravarti Debabrata, Nagata Kyosuke, O'Hare Peter
Marie Curie Research Institute, The Chart, Oxted, Surrey RH8 0TL, UK.
Department of Infection Biology, Institute of Basic Medical Sciences, University of Tsukuba, 1-1-1 Tennohdai, Tsukuba 305-8575, Japan.
J Gen Virol. 2003 Sep;84(Pt 9):2501-2510. doi: 10.1099/vir.0.19326-0.
Affinity chromatography was used to identify cellular proteins that interact with the herpes simplex virus (HSV) tegument protein VP22. Among a small set of proteins that bind specifically to VP22, we identified TAF-I (template-activating factor I), a chromatin remodelling protein and close homologue of the histone chaperone protein NAP-1. TAF-I has been shown previously to promote more ordered transfer of histones to naked DNA through a direct interaction with histones. TAF-I, as a subunit of the INHAT (inhibitor of acetyltransferases) protein complex, also binds to histones and masks them from being substrates for the acetyltransferases p300 and PCAF. Using in vitro assays for TAF-I activity in chromatin assembly, we show that VP22 inhibits nucleosome deposition on DNA by binding to TAF-I. We also observed that VP22 binds non-specifically to DNA, an activity that is abolished by TAF-I. However, the presence of VP22 does not affect the property of INHAT in inhibiting the histone acetyltransferase activity of p300 or PCAF in vitro. We speculate that this interaction could be relevant to HSV DNA organization early in infection, for example, by interfering with nucleosomal deposition on the genome. Consistent with this possibility was the observation that overexpression of TAF-I in transfected cells interferes with the progression of HSV-1 infection.
亲和层析法被用于鉴定与单纯疱疹病毒(HSV)被膜蛋白VP22相互作用的细胞蛋白。在一小组与VP22特异性结合的蛋白中,我们鉴定出了TAF-I(模板激活因子I),一种染色质重塑蛋白,也是组蛋白伴侣蛋白NAP-1的紧密同源物。先前已表明TAF-I通过与组蛋白直接相互作用促进组蛋白更有序地转移至裸露的DNA。TAF-I作为INHAT(乙酰转移酶抑制剂)蛋白复合物的一个亚基,也与组蛋白结合,使其不能成为乙酰转移酶p300和PCAF的底物。通过对染色质组装中TAF-I活性进行体外测定,我们发现VP22通过与TAF-I结合抑制核小体在DNA上的沉积。我们还观察到VP22能非特异性地与DNA结合,而TAF-I可消除这种活性。然而,VP22的存在并不影响INHAT在体外抑制p300或PCAF的组蛋白乙酰转移酶活性的特性。我们推测这种相互作用可能与感染早期HSV的DNA组织有关,例如,通过干扰核小体在基因组上的沉积。与此可能性相符的是,在转染细胞中过表达TAF-I会干扰HSV-1感染的进程。